{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:52:30Z","timestamp":1792788750286,"version":"4.5.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Mildred Scheel School of Oncology Cologne-Bonn","award":["70113307"],"award-info":[{"award-number":["70113307"]}]},{"name":"Ministry of Culture and Science of the State of North Rhine-Westphalia","award":["NW21-062H"],"award-info":[{"award-number":["NW21-062H"]}]},{"DOI":"10.13039\/501100016374","name":"Medizinische Fakult\u00c3\u00a4t, Rheinische Friedrich-Wilhelms-Universit\u00c3\u00a4t Bonn","doi-asserted-by":"publisher","award":["2019-FKS-12"],"award-info":[{"award-number":["2019-FKS-12"]}],"id":[{"id":"10.13039\/501100016374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Tumor organoid models have emerged as a promising tool in cancer research. By preserving intra- and intertumoral heterogeneity and structural integrity they provide a physiologically relevant platform for drug-response studies. However, valid methodological approaches for cell death analyses applying flow cytometry, particularly in complex, large organoids, are lacking. Using glioblastoma organoids (GBOs), we developed a flow cytometry protocol to quantify cell death as an important readout in cancer research. Human GBOs were generated out of tumor material from six patients. Temozolomide (TMZ) and lomustine (CCNU) were used as cytotoxic agents commonly employed in glioblastoma therapy. After treatment for 144 and 288 hours, single cell suspensions from densely-packed GBOs were generated through a combined approach of enzymatic and mechanical dissociation. Cells were permeabilized with Triton X and subsequently stained with propidium iodide (PI). PI staining labels fragmented nuclear DNA, yielding a hypodiploid sub-G1 peak in flow cytometry that markes cell death. After treatment for 288 hours with physiologically-relevant concentrations of TMZ and CCNU cell death rates reached up to 63% in our GBO model. Across three GBO populations, the impact of CCNU at the given concentration was more pronounced compared to that observed with TMZ and the cell death rates of treatment for 288 hours surpassed that of the 144-hour treatment. Both biological and technical replicates showed low variability. Hoechst 33258 staining on the same samples confirmed trends in cell death rates obtained from PI-based analysis. We further validated the treatment-induced effect using a plate-based lactate dehydrogenase release assay and measurements of GBO diameter. Our single-stain flow-cytometry protocol scales to large, dense organoids and provides a practical balance of performance, hands-on time, cost, specificity, and throughput. This protocol could support development and evaluation of subtype-specific therapeutic strategies in translational cancer research.<\/jats:p>","DOI":"10.1371\/journal.pone.0327660","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T17:33:53Z","timestamp":1758648833000},"page":"e0327660","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical note"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5710-6557","authenticated-orcid":true,"given":"Anna-Laura","family":"Potthoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Chun","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Melhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna S.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara E. F.","family":"Pregler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Vieregge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Raspe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea L.","family":"Friker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zeyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7692-7775","authenticated-orcid":true,"given":"Julian P.","family":"Layer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Dolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieta I.","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Waha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Pietsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike-Andrew","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Vatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"H\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Herrlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"issue":"7","key":"pone.0327660.ref001","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling Development and Disease with Organoids","volume":"165","author":"H Clevers","year":"2016","journal-title":"Cell"},{"issue":"7","key":"pone.0327660.ref002","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/2472555220915827","article-title":"Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response","volume":"25","author":"S Kim","year":"2020","journal-title":"SLAS Discov"},{"issue":"2","key":"pone.0327660.ref003","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.gendis.2023.02.052","article-title":"Cancer organoids: A platform in basic and translational research","volume":"11","author":"X Ma","year":"2023","journal-title":"Genes Dis"},{"key":"pone.0327660.ref004","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fcell.2020.00220","article-title":"Organoid Models of Glioblastoma to Study Brain Tumor Stem Cells","volume":"8","author":"R Azzarelli","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"pone.0327660.ref005","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid Modeling of the Tumor Immune Microenvironment","volume":"175","author":"JT Neal","year":"2018","journal-title":"Cell"},{"key":"pone.0327660.ref006","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Z Zhao","year":"2022","journal-title":"Nat Rev Methods Primers"},{"issue":"8","key":"pone.0327660.ref007","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41416-020-0993-5","article-title":"Current concepts in tumour-derived organoids","volume":"123","author":"RJ Porter","year":"2020","journal-title":"Br J Cancer"},{"issue":"1","key":"pone.0327660.ref008","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41420-025-02505-w","article-title":"Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: a cutting-edge tool for advancing personalised treatments","volume":"11","author":"Q Wang","year":"2025","journal-title":"Cell Death Discov"},{"issue":"9","key":"pone.0327660.ref009","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"SZ Wu","year":"2021","journal-title":"Nat Genet"},{"issue":"6","key":"pone.0327660.ref010","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2018.11.013","article-title":"Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids","volume":"175","author":"H Hu","year":"2018","journal-title":"Cell"},{"issue":"11","key":"pone.0327660.ref011","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/neuonc\/noab155","article-title":"Newly established patient-derived organoid model of intracranial meningioma","volume":"23","author":"S Yamazaki","year":"2021","journal-title":"Neuro Oncol"},{"issue":"12","key":"pone.0327660.ref012","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1038\/s41596-020-0402-9","article-title":"Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing","volume":"15","author":"F Jacob","year":"2020","journal-title":"Nat Protoc"},{"issue":"1","key":"pone.0327660.ref013","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity","volume":"180","author":"F Jacob","year":"2020","journal-title":"Cell"},{"issue":"9","key":"pone.0327660.ref014","doi-asserted-by":"crossref","first-page":"110604","DOI":"10.1016\/j.isci.2024.110604","article-title":"Patient-derived tumor organoids mimic treatment-induced DNA damage response in glioblastoma","volume":"27","author":"B Majc","year":"2024","journal-title":"iScience"},{"issue":"1","key":"pone.0327660.ref015","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41598-024-84284-5","article-title":"Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma","volume":"15","author":"AS L\u00fcck","year":"2025","journal-title":"Sci Rep"},{"issue":"11","key":"pone.0327660.ref016","article-title":"Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids","volume":"8","author":"Y Zhao","year":"2021","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"pone.0327660.ref017","doi-asserted-by":"crossref","first-page":"353","DOI":"10.20892\/j.issn.2095-3941.2023.0061","article-title":"Development of glioblastoma organoids and their applications in personalized therapy","volume":"20","author":"C Xu","year":"2023","journal-title":"Cancer Biol Med"},{"issue":"1","key":"pone.0327660.ref018","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12885-018-4238-4","article-title":"Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models","volume":"18","author":"S Tsai","year":"2018","journal-title":"BMC Cancer"},{"issue":"2","key":"pone.0327660.ref019","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcmgh.2020.09.003","article-title":"Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance","volume":"11","author":"J Liu","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"7","key":"pone.0327660.ref020","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1084\/jem.20171385","article-title":"Itraconazole targets cell cycle heterogeneity in colorectal cancer","volume":"215","author":"SJA Buczacki","year":"2018","journal-title":"J Exp Med"},{"issue":"8","key":"pone.0327660.ref021","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-022-00475-0","article-title":"Disconnecting multicellular networks in brain tumours","volume":"22","author":"V Venkataramani","year":"2022","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"pone.0327660.ref022","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13063-021-05977-0","article-title":"Phase I\/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth\/NOA-24 trial","volume":"23","author":"T Zeyen","year":"2022","journal-title":"Trials"},{"issue":"11","key":"pone.0327660.ref023","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1093\/neuonc\/noab092","article-title":"Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma","volume":"23","author":"M Schneider","year":"2021","journal-title":"Neuro Oncol"},{"issue":"6","key":"pone.0327660.ref024","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/cancers11060858","article-title":"Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide","volume":"11","author":"A-L Potthoff","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"pone.0327660.ref025","doi-asserted-by":"crossref","first-page":"16645","DOI":"10.1038\/s41598-017-16622-9","article-title":"Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids","volume":"7","author":"A-L Bulin","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0327660.ref026","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1038\/srep03751","article-title":"An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models","volume":"4","author":"JP Celli","year":"2014","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0327660.ref027","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.7150\/thno.91362","article-title":"Construction of tumor organoids and their application to cancer research and therapy","volume":"14","author":"J Lv","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"pone.0327660.ref028","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12079-018-0498-7","article-title":"A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer","volume":"13","author":"SI Djomehri","year":"2019","journal-title":"J Cell Commun Signal"},{"issue":"12","key":"pone.0327660.ref029","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/eji.202170126","article-title":"Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)","volume":"51","author":"A Cossarizza","year":"2021","journal-title":"Eur J Immunol"},{"issue":"9","key":"pone.0327660.ref030","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot087205","article-title":"Analyzing Cell Death by Nuclear Staining with Hoechst 33342","volume":"2016","author":"LC Crowley","year":"2016","journal-title":"Cold Spring Harb Protoc"},{"issue":"2","key":"pone.0327660.ref031","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"I Nicoletti","year":"1991","journal-title":"J Immunol Methods"},{"issue":"3","key":"pone.0327660.ref032","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/nprot.2006.238","article-title":"Analysis of apoptosis by propidium iodide staining and flow cytometry","volume":"1","author":"C Riccardi","year":"2006","journal-title":"Nat Protoc"},{"issue":"5","key":"pone.0327660.ref033","first-page":"1205","article-title":"Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases","volume":"151","author":"Z Dong","year":"1997","journal-title":"Am J Pathol"},{"issue":"5","key":"pone.0327660.ref034","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0002-9440(10)64291-5","article-title":"Early necrotic DNA degradation: presence of blunt-ended DNA breaks, 3\u2019 and 5\u2019 overhangs in apoptosis, but only 5\u2019 overhangs in early necrosis","volume":"162","author":"VV Didenko","year":"2003","journal-title":"Am J Pathol"},{"issue":"10172","key":"pone.0327660.ref035","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(18)31791-4","article-title":"Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG\/NOA-09): a randomised, open-label, phase 3 trial","volume":"393","author":"U Herrlinger","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"pone.0327660.ref036","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/ph14030195","article-title":"Inhibition of Intercellular Cytosolic Traffic via Gap Junctions Reinforces Lomustine-Induced Toxicity in Glioblastoma Independent of MGMT Promoter Methylation Status","volume":"14","author":"M Schneider","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"pone.0327660.ref037","volume-title":"Central nervous system tumours","author":"World Health Organization","year":"2021"},{"issue":"3","key":"pone.0327660.ref038","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1878-0261.13786","article-title":"Tonabersat enhances temozolomide-mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibition","volume":"19","author":"ENC Schmidt","year":"2025","journal-title":"Mol Oncol"},{"issue":"10","key":"pone.0327660.ref039","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"R Stupp","year":"2005","journal-title":"N Engl J Med"},{"issue":"22","key":"pone.0327660.ref040","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1158\/1078-0432.CCR-09-1349","article-title":"The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation","volume":"15","author":"J Portnow","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"7","key":"pone.0327660.ref041","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/ijc.29908","article-title":"A paired comparison between glioblastoma \u201cstem cells\u201d and differentiated cells","volume":"138","author":"M Schneider","year":"2016","journal-title":"Int J Cancer"},{"issue":"11","key":"pone.0327660.ref042","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.3390\/ijms9112265","article-title":"Ponicidin inhibits monocytic leukemia cell growth by induction of apoptosis","volume":"9","author":"J-J Liu","year":"2008","journal-title":"Int J Mol Sci"},{"issue":"2","key":"pone.0327660.ref043","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bbrc.2003.09.052","article-title":"Hoechst 33258 binds to G-quadruplex in the promoter region of human c-myc","volume":"310","author":"S Maiti","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"pone.0327660.ref044","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12915-021-00972-y","article-title":"Plasma membrane integrity: implications for health and disease","volume":"19","author":"DA Ammendolia","year":"2021","journal-title":"BMC Biol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0327660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T17:33:59Z","timestamp":1758648839000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0327660"}},"subtitle":[],"editor":[{"given":"Joseph Alan","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0327660","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]}}}